TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.

Tibet Cheezheng Tibetan Medicine Co., Ltd.

002287

CNE100000FM9

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2025-01-14			5-day change	1st Jan Change
20.58 ^CNY	+1.58%		-2.09%	-3.83%

Oct. 29	Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
Jul. 30	Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI

Tibet Cheezheng Tibetan Medicine Co., Ltd. Approves Cash Dividend for the Year 2023

May 13, 2024 at 03:32 pm EDT

Tibet Cheezheng Tibetan Medicine Co., Ltd. held its Annual General Meeting of 2023 on 10 May 2024, approved cash dividend per 10 shares (tax included) of CNY 4.80000000.

Latest news about Tibet Cheezheng Tibetan Medicine Co., Ltd.

Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	24-10-29	CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	24-07-30	CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Approves the Election of Guo De'an as Independent Director	24-04-28	CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	24-04-26	CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	24-04-18	CI
Tibet Cheezheng Tibetan Medicine's Profit Rises 29.5% in 2023; Shares Up 5%	24-02-23	MT
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-28	CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
Tibet Cheezheng Tibetan Medicine Logs 34.1% Drop in 2022 Profit	23-02-20	MT
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-28	CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-17	CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-25	CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-07-27	CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-26	CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-15	CI
Gansu Foge Tibetan Medicine Co., Ltd. announced that it expects to receive CNY 790.500216 million in funding from Tibet Cheezheng Tibetan Medicine Co., Ltd. and other investors	20-12-03	CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-22	CI
Tibet Cheezheng Tibetan Medicine Co., Ltd.(XSEC:002287) added to FTSE All-World Index	20-09-21	CI
Tibet Cheezheng Tibetan Medicine Co., Ltd.(XSEC:002287) added to S&P Global BMI Index	20-09-21	CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-27	CI
Gansu Foge Tibetan Medicine Co., Ltd. announced that it has received CNY 192.9802 million in funding from Tibet Cheezheng Tibetan Medicine Co., Ltd.	20-08-19	CI

Chart Tibet Cheezheng Tibetan Medicine Co., Ltd.

Duration

Period

Chart Tibet Cheezheng Tibetan Medicine Co., Ltd.

002287: Dynamic Chart

Tibet Cheezheng Tibetan Medicine Co., Ltd is a China-based company, principally engaged in the research, development, manufacture and distribution of Tibetan medicines. The Company primarily offers medicines under emplastrum, ointment, granule, crude drugs and others. The Company's products include external pain relieving series, including Cheezheng Xiaotong emplastrum, Qingpeng ointment and Baimai ointment, as well as oral medicine series. The Company distributes its products within domestic market and to overseas markets.

Employees

3,091

Sector

Pharmaceuticals

Calendar

2025-04-17 - Q4 2024 Earnings Release (Projected)

More about the company